Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals

Supplemental Data

• Supplemental Figure S1 (.xlsx, 218 KB) - kinase proteins measured by MIB-MS during HCMV infection
• Supplemental Figure S2 (.xlsx, 2.4 MB) - List of kinase peptides measured by MIB-MS during HCMV infection
• Table S3 (.xlsx, 29 KB) - .zip file containing individual graphs of linear mixed model analysis for all kinases present in all replicates
• Table S4 (.xlsx, 66 KB) - List of kinases significantly changed compared to uninfected cells at each time after infection
• Table S5 (.xlsx, 24 KB) - Signaling pathways associated with kinases increased after infection
• Table S6 (.xlsx, 26 KB) - Signaling pathways associated with kinases decreased after infection
• Table S7 (.xlsx, 424 KB) - Kinase protein changes in the presence of dinaciclib
• Table S8 (.xlsx, 38 KB) - Kinase peptide changes in the presence of dinaciclib
• Figure S1 (.zip, 59.1 MB) - .zip file containing individual graphs of linear mixed model analysis of kinases present in all samples
• Figure S2 (.jpg, 695 KB) - Bar graph showing kinome changes after AD169 infection
• Figrue S3 (.jpg, 815 KB) - Bar graph showing kinome changes after AD169 infection
• Figure S4 (.jpg, 786 KB) - Bar graph showing changes in kinase recovery in the presence of dinaciclib